Clinical trial
A Study for the Treatment of Painful Diabetic Neuropathy
NCT00058968 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00058968 |
|---|---|
| Title | A Study for the Treatment of Painful Diabetic Neuropathy |
| Official title | Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy, Painful |
| Intervention type | Drug |
| Interventions | Duloxetine hydrochloride, placebo |
| Enrollment | 660 |
| Start date | Oct 1, 2002 |
| Completion | Mar 1, 2005 |
| First posted | Apr 16, 2003 |
| Last update posted | May 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: